Almiitron Softgel Gelatin Capsules x6

Almiitron Softgel is a combination antimalarial medication containing artemether and lumefantrine. This fixed-dose combination therapy is designed to treat acute, uncomplicated malaria caused by Plasmodium falciparum. Almiitron Softgel offers an effective and well-tolerated treatment option for malaria, particularly in areas where drug resistance is a concern.

Uses

Almiitron Softgel is primarily used for:

• Treatment of acute, uncomplicated malaria caused by Plasmodium falciparum
• Management of malaria in areas with multi-drug resistant strains
• Treatment of mixed infections including P. falciparum

Benefits

• Effective against drug-resistant strains of malaria parasites
• Rapid reduction of parasite load
• Reduces risk of progression to severe malaria
• Well-tolerated with a good safety profile
• Convenient fixed-dose combination

How It Works

Artemether, a fast-acting artemisinin derivative, rapidly reduces the parasite biomass. It interferes with the parasite’s ability to detoxify heme, leading to parasite death. Lumefantrine, a slower-acting antimalarial, eliminates residual parasites and prevents recrudescence. This combination provides both rapid symptom relief and sustained antimalarial action.

Dosage

The dosage of Almiitron Softgel is based on body weight. Typically, it is administered as a 3-day course with six doses in total. The first two doses are given 8 hours apart on the first day, followed by two doses per day for the next two days. Always follow your healthcare provider’s instructions regarding dosage and duration of treatment.

Side Effects

Common side effects may include headache, dizziness, fatigue, loss of appetite, nausea, vomiting, abdominal pain, and muscle or joint pain. These are usually mild and transient. Serious side effects are rare but can include severe allergic reactions, abnormal heart rhythms, or liver problems. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Warning

Almiitron Softgel should not be used for malaria prevention. It is not recommended for patients with severe malaria or certain heart conditions. Caution is advised in patients with liver or kidney impairment. This medication may cause dizziness and affect the ability to drive or operate machinery.

Interactions

• CYP3A4 inhibitors or inducers
• Antiretroviral medications
• Certain antidepressants
• Antifungal medications
• Grapefruit juice

Important Information

Take Almiitron Softgel with food or milk to increase absorption. Complete the full course of treatment even if symptoms improve. If vomiting occurs within 1 hour of dosing, repeat the dose. Avoid grapefruit juice during treatment. Seek medical attention if fever persists or returns within 28 days after treatment. Use effective birth control during and for 4 weeks after treatment if pregnant.